CA 15-3 is a predictive and prognostic biomarker in patients with metastasized breast cancer undergoing selective internal radiation therapy

Yvonne Nadine Fahmueller, Dorothea Nagel, Ralf Thorsten Hoffmann, Klaus Tatsch, Tobias Jakobs, Petra Stieber, Stefan Holdenrieder

Research output: Contribution to journalArticlepeer-review

4 Scopus citations
Original languageEnglish
Pages (from-to)63-66
Number of pages4
JournalInternational Journal of Clinical Pharmacology and Therapeutics
Issue number1
StatePublished - Jan 2013
Externally publishedYes


  • Biomarker
  • Breast cancer
  • CA 15-3
  • Selective Internal Radiation Therapy (SIRT)

Cite this